We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Your guide to a disrupted world
Add this topic to your myFT Digest for news straight to your inbox
Scotland remains the nation hit hardest by the surge, according to the ONS
New three-year contract in place if UK drugmaker continues to manufacture the jab
FT science editor Clive Cookson and global pharma correspondent Hannah Kuchler answered your questions about rising Omicron infections and vaccine efficiency
Change would incorporate genetic material from fast-spreading strain in new boosters
The global south has once again been abandoned in its quest for vaccines
Apiaries subject to Covid-style restrictions to save pollinators crucial to agricultural sector
Hotel confinement for international visitors cut by half as Beijing tries to revive the economy
Remote providers report a leap in requests as conservative US states roll out a number of restrictions
Washington seeks to expand domestic production of crucial component of mRNA vaccines
Short break in immune suppression treatment improves antibody production after vaccination while doing little harm
The new buzzword for Chinese people sick of being locked down is ‘runxue’: the study of leaving the country completely
New vaccine candidates significantly outperform existing Covid jabs at targeting the most prevalent strain
UK surge in infection rates, US faces recession, give women their Wimbledon due
Scotland hit hardest in the UK as cases climb 40% to leave one in 20 people suffering from the disease
Governments need to plan now for what could be a tough autumn
WHO debates raising classification of outbreak as some authorities widen eligibility for vaccines
Pharma companies are hoping to catch up with rivals as they report promising trial results for jab
Mathematical modelling looked at deaths directly and indirectly linked to jabs
Javid says he asked officials to revise previous plans that would exclude under-65s
Xi Jinping orders public health policy to prioritise Covid control over all other diseases
UK health agency investigating possibility of community transmission says risk to public ‘extremely low’
US biotech group says shot targeting both first strain and Omicron could help avert ‘large rise’ in cases
Government seeks to secure domestic jab supply and prepare for future pandemics in deal with Boston biotech
This legal manoeuvre is setting a new precedent for corporations to evade accountability in America
After years in retreat, the disease is once again on the rise across the continent
International Edition
